UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients

European journal of cancer (1990), 2010-04, Vol.46 (6), p.1033-1040

2010

Volltextzugriff (PDF)

Decision-making in the end-of-life phase of high-grade glioma patients

European journal of cancer (1990), 2012-01, Vol.48 (2), p.226-232

2012

Volltextzugriff (PDF)

An Online Calculator for the Prediction of Survival in Glioblastoma Patients Using Classical Statistics and Machine Learning

Neurosurgery, 2020-02, Vol.86 (2), p.E184-E192

2020

Volltextzugriff (PDF)

Treatment of cognitive deficits in brain tumour patients: current status and future directions

Current opinion in oncology, 2019-11, Vol.31 (6), p.540-547

2019

Volltextzugriff (PDF)

Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951

Journal of clinical oncology, 2013-01, Vol.31 (3), p.344-350

2013

Volltextzugriff (PDF)

The effects of age on health-related quality of life in cancer populations: A pooled analysis of randomized controlled trials using the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 involving 6024 cancer patients

European journal of cancer (1990), 2015-12, Vol.51 (18), p.2808-2819

2015

Volltextzugriff (PDF)

Health-Related Quality of Life in a Randomized Phase III Study of Bevacizumab, Temozolomide, and Radiotherapy in Newly Diagnosed Glioblastoma

Journal of clinical oncology, 2015-07, Vol.33 (19), p.2166-2175

2015

Volltextzugriff (PDF)

Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034

Journal of clinical oncology, 2009-03, Vol.27 (8), p.1268-1274

2009

Volltextzugriff (PDF)

Compromised Health-Related Quality of Life in Patients With Low-Grade Glioma

Journal of clinical oncology, 2011-11, Vol.29 (33), p.4430-4435

2011

Volltextzugriff (PDF)

Cognitive Rehabilitation in Patients With Gliomas: A Randomized, Controlled Trial

Journal of clinical oncology, 2009-08, Vol.27 (22), p.3712-3722

2009

Volltextzugriff (PDF)

Long-Term Disease Burden and Survivorship Issues After Surgery and Radiotherapy of Intracranial Meningioma Patients

Neurosurgery, 2021-01, Vol.88 (1), p.155-164

2021

Volltextzugriff (PDF)

Impact of timing of antiseizure medication withdrawal on seizure recurrence in glioma patients: a retrospective observational study

Journal of neuro-oncology, 2023-09, Vol.164 (3), p.545-555

2023

Volltextzugriff (PDF)

MGMT Promoter Methylation Is Prognostic but Not Predictive for Outcome to Adjuvant PCV Chemotherapy in Anaplastic Oligodendroglial Tumors: A Report From EORTC Brain Tumor Group Study 26951

Journal of clinical oncology, 2009-12, Vol.27 (35), p.5881-5886

2009

Volltextzugriff (PDF)

The level of patient-reported outcome reporting in randomised controlled trials of brain tumour patients: A systematic review

European journal of cancer (1990), 2014-09, Vol.50 (14), p.2432-2448

2014

Volltextzugriff (PDF)

The end-of-life phase of high-grade glioma patients: a systematic review

Supportive care in cancer, 2014-03, Vol.22 (3), p.847-857

2014

Volltextzugriff (PDF)

Evaluating the lack of impact of the e-health application Oncokompas on outcomes in incurably ill cancer patients

The Lancet regional health. Europe, 2022-07, Vol.18, p.100396-100396, Article 100396

2022

Volltextzugriff (PDF)

New clinical, pathological and molecular prognostic models and calculators in patients with locally diagnosed anaplastic oligodendroglioma or oligoastrocytoma. A prognostic factor analysis of European Organisation for Research and Treatment of Cancer Brain Tumour Group Study 26951

European journal of cancer (1990), 2013-11, Vol.49 (16), p.3477-3485

2013

Volltextzugriff (PDF)

A qualitative study on the healthcare experiences of adolescents and young adults (AYA) with an uncertain or poor cancer prognosis

Supportive care in cancer, 2023-12, Vol.31 (12), p.721-721, Article 721

2023

Volltextzugriff (PDF)

Health-Related Quality of Life or Quantity of Life: A Difficult Trade-Off in Primary Brain Tumors?

Seminars in oncology, 2014-08, Vol.41 (4), p.541-552

2014

Volltextzugriff (PDF)

Imaging necrosis during treatment is associated with worse survival in EORTC 26101 study

Neurology, 2019-06, Vol.92 (24), p.e2754

2019

Volltextzugriff (PDF)

The impact of bevacizumab on health-related quality of life in patients treated for recurrent glioblastoma: Results of the randomised controlled phase 2 BELOB trial

European journal of cancer (1990), 2015-07, Vol.51 (10), p.1321-1330

2015

Volltextzugriff (PDF)

The Impact of the Timing of Health-Related Quality of Life Assessments on the Actual Results in Glioma Patients: A Randomized Prospective Study

Cancers, 2020-08, Vol.12 (8), p.2172

2020

Volltextzugriff (PDF)

Neurocognitive sequelae in the treatment of low-grade gliomas

Seminars in oncology, 2003-12, Vol.30 (6), p.45-48

Taphoorn, Martin J.B

2003

Volltextzugriff (PDF)

1 – 25 von 226

Suche als RSS-Feed

Aktive Filter

SpracheEnglisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(197)
Mit Volltextzugriff
(202)

Publikationsform

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients

Decision-making in the end-of-life phase of high-grade glioma patients

An Online Calculator for the Prediction of Survival in Glioblastoma Patients Using Classical Statistics and Machine Learning

Treatment of cognitive deficits in brain tumour patients: current status and future directions

Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951

The effects of age on health-related quality of life in cancer populations: A pooled analysis of randomized controlled trials using the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 involving 6024 cancer patients

Health-Related Quality of Life in a Randomized Phase III Study of Bevacizumab, Temozolomide, and Radiotherapy in Newly Diagnosed Glioblastoma

Current state of quality of life and patient-reported outcomes research

Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034

Compromised Health-Related Quality of Life in Patients With Low-Grade Glioma

Cognitive Rehabilitation in Patients With Gliomas: A Randomized, Controlled Trial

Long-Term Disease Burden and Survivorship Issues After Surgery and Radiotherapy of Intracranial Meningioma Patients

Adjuvant Procarbazine, Lomustine, and Vincristine Improves Progression-Free Survival but Not Overall Survival in Newly Diagnosed Anaplastic Oligodendrogliomas and Oligoastrocytomas: A Randomized European Organisation for Research and Treatment of Cancer Phase III Trial

Impact of timing of antiseizure medication withdrawal on seizure recurrence in glioma patients: a retrospective observational study

MGMT Promoter Methylation Is Prognostic but Not Predictive for Outcome to Adjuvant PCV Chemotherapy in Anaplastic Oligodendroglial Tumors: A Report From EORTC Brain Tumor Group Study 26951

The level of patient-reported outcome reporting in randomised controlled trials of brain tumour patients: A systematic review

The end-of-life phase of high-grade glioma patients: a systematic review

Evaluating the lack of impact of the e-health application Oncokompas on outcomes in incurably ill cancer patients

New clinical, pathological and molecular prognostic models and calculators in patients with locally diagnosed anaplastic oligodendroglioma or oligoastrocytoma. A prognostic factor analysis of European Organisation for Research and Treatment of Cancer Brain Tumour Group Study 26951

A qualitative study on the healthcare experiences of adolescents and young adults (AYA) with an uncertain or poor cancer prognosis

Health-Related Quality of Life or Quantity of Life: A Difficult Trade-Off in Primary Brain Tumors?

Imaging necrosis during treatment is associated with worse survival in EORTC 26101 study

The impact of bevacizumab on health-related quality of life in patients treated for recurrent glioblastoma: Results of the randomised controlled phase 2 BELOB trial

The Impact of the Timing of Health-Related Quality of Life Assessments on the Actual Results in Glioma Patients: A Randomized Prospective Study

Neurocognitive sequelae in the treatment of low-grade gliomas

Aktive Filter

Suchergebnisse filtern